Inventor · disambiguated record
Jiwen Liu
Also filed as: LIU JIWEN
29 granted patents·23 pending applications·509 citations·filing 2000–2024
97Inventor score
Top patents by PatentIndex Score
52 records- 0195US7541383B2Asthma and allergic inflammation modulatorsAMGEN INC·Filed 2007·Granted Jun 2, 2009·86 cites·24 claims
- 0295US6316503B1LXR modulatorsTULARIK INC·Filed 2000·Granted Nov 13, 2001·100 cites·47 claims
- 0394US7582803B2Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disordersAMGEN INC·Filed 2006·Granted Sep 1, 2009·17 cites·19 claims
- 0492US7375102B2Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido[2,3-D]pyrimidin-4(3H)-one-related compounds, compositions and methods for their useAMGEN SF LLC·Filed 2005·Granted May 20, 2008·27 cites·24 claims
- 0592US7053215B2Substituted Quinazolin-4(3H)-one compounds, compositions, and methods for their useAMGEN SF LLC·Filed 2002·Granted May 30, 2006·47 cites·18 claims
- 0691US7939538B2Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseasesAMGEN INC·Filed 2005·Granted May 10, 2011·20 cites·23 claims
- 0791US7067662B2CXCR3 antagonistsAMGEN SF LLC·Filed 2004·Granted Jun 27, 2006·31 cites·20 claims
- 0890US6964967B2Substituted pyrido[2,3-d]pyrimidines and methods for their useAMGEN INC·Filed 2001·Granted Nov 15, 2005·35 cites·28 claims
- 0989US7816367B2Compounds, pharmaceutical compositions and methods for use in treating metabolic disordersAMGEN INC·Filed 2005·Granted Oct 19, 2010·15 cites·25 claims
- 1088US9593129B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2016·Granted Mar 14, 2017·5 cites·18 claims
- 1188US9296736B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2014·Granted Mar 29, 2016·7 cites·13 claims
- 1288US7321001B2Asthma and allergic inflammation modulatorsAMGEN INC·Filed 2003·Granted Jan 22, 2008·39 cites·25 claims
- 1388US6884782B2STAT modulatorsAMGEN INC·Filed 2001·Granted Apr 26, 2005·23 cites·102 claims
- 1487US11564928B1Cannabinoid receptor type 2 (CB2) modulators and uses thereofTEON THERAPEUTICS INC·Filed 2022·Granted Jan 31, 2023·1 cites·19 claims
- 1587US2024300892A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2023·Application pending·0 cites
- 1686US8030354B2Substituted biphenyl GPR40 modulatorsAMGEN INC·Filed 2008·Granted Oct 4, 2011·11 cites·96 claims
- 1785US7649110B2Compounds, pharmaceutical compositions and methods for use in treating metabolic disordersAMGEN INC·Filed 2005·Granted Jan 19, 2010·8 cites·37 claims
- 1883US8450522B2Conformationally constrained carboxylic acid derivatives useful for treating metabolic disordersBROWN SEAN P·Filed 2009·Granted May 28, 2013·9 cites·17 claims
- 1983US7687526B2Benzo-fused compounds for use in treating metabolic disordersAMGEN INC·Filed 2007·Granted Mar 30, 2010·5 cites·18 claims
- 2080US2022169611A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2022·Application pending·0 cites
- 2179US2024252504A1Cannabinoid receptor type 2 (cb2) modulators and uses thereofTEON THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2278US7465804B2Compounds, pharmaceutical compositions and methods for their use in treating metabolic disordersAMGEN INC·Filed 2006·Granted Dec 16, 2008·3 cites·48 claims
- 2374US11957689B2Cannabinoid receptor type 2 (CB2) modulators and uses thereofTEON THERAPEUTICS INC·Filed 2022·Granted Apr 16, 2024·0 cites·9 claims
- 2474US8558105B2Organic optoelectronic devices and applications thereofCARROLL DAVID LOREN·Filed 2006·Granted Oct 15, 2013·4 cites·59 claims
- 2574US2021179560A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2020·Application pending·0 cites
- 2673US8748462B2Spirocyclic GPR40 modulatorsBROWN SEAN P·Filed 2009·Granted Jun 10, 2014·2 cites·25 claims
- 2773US8003648B2Heterocyclic GPR40 modulatorsAMGEN INC·Filed 2009·Granted Aug 23, 2011·1 cites·10 claims
- 2872US11124515B2Adenosine receptor antagonists and uses thereofTEON THERAPEUTICS INC·Filed 2021·Granted Sep 21, 2021·0 cites·22 claims
- 2971US2022056033A1Adenosine receptor antagonists and uses thereofTEON THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3069US8183293B2Phenyl acetic acid derivativesGRILLO MARK·Filed 2008·Granted May 22, 2012·2 cites·20 claims
- 3167US2019062276A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2018·Application pending·0 cites
- 3266US2021040097A1Adenosine receptor antagonists and uses thereofTEON THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3365US2014011796A1Piperidinone derivatives as mdm2 inhibitors for the treatment of cancerAMGEN INC·Filed 2013·Application pending·0 cites
- 3464US2009275598A1Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disordersAMGEN INC·Filed 2009·Application pending·0 cites
- 3564US2017144971A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2017·Application pending·0 cites
- 3663US2005101540A1STAT modulatorsAMGEN INC·Filed 2004·Application pending·0 cites
- 3760USD903849SSolar lighting fanNINGBO EFU ELECTRICAL APPLIANCE CO LTD·Filed 2019·Granted Dec 1, 2020·11 cites·1 claims
- 3856US7714008B2Heterocyclic GPR40 modulatorsAMGEN INC·Filed 2007·Granted May 11, 2010·0 cites·11 claims
- 3956US2013179241A1Universal loyalty program and system, which can include aspects in food and medicine recall, anti-counterfeiting, anti-identity theft, anti-credit card fraud and moreLIU JIWEN·Filed 2013·Application pending·0 cites
- 4055US2006116388A1CXCR3 antagonistsAMGNEN SF LLC·Filed 2006·Application pending·0 cites
- 4154US2023365564A1Cocrystals of an adenosine a2b receptor antagonistTEON THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4253US2023192704A1Monocarboxylic acid transporter 4 (mct4) modulators and uses thereofTEON THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4351US2023024108A1Adenosine a2a receptor antagonistsTEON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4450US7960567B2Compounds and methods useful for treating asthma and allergic inflammationAMGEN INC·Filed 2008·Granted Jun 14, 2011·0 cites·19 claims
- 4548US2024041889A1Combination therapy with adenosine receptor antagonistsTEON THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4648US2022324803A1Prostaglandin e2 receptor 4 antagonists and uses thereofTEON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4746US2007244155A1Bicyclic carboxylic acid derivatives useful for treating metabolic disordersAMGEN INC·Filed 2007·Application pending·0 cites
- 4845US2010307580A1Lateral Organic Optoelectronic Devices And Applications ThereofCARROLL DAVID LOREN·Filed 2008·Application pending·0 cites
- 4943US2010137323A1Benzo-fused compounds for use in treating metabolic disordersAMGEN INC·Filed 2010·Application pending·0 cites
- 5041US2005038070A1Asthma and allergic inflammation modulatorsAMGEN INC·Filed 2004·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jiwen Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →